Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Orphan Drug Policy Changes To Be Considered Under US FDA's FY 2019 Budget Proposal

Apr 05 2018

• By Derrick Gingery

FDAEntrance_1200x675

Related Content

Trump's Budget Surprise: FDA Gains 13% Increase

Feb 12 2018

FDA Highlights Advanced Drug Manufacturing Approaches In Budget Plan

Feb 13 2018

Orphan Drug Development: Could We Be Seeing The End Of P Values?

Mar 20 2018

US FDA Doesn't Support Creating Ultra-Orphan Designation

Dec 20 2017

Orphan Designations For Pediatric Subgroups Of Common Diseases To End

Dec 19 2017

Orphan Drug Pricing Heading To Negotiating Table in US?

Jun 06 2017

Additional Topics

United States Rare Diseases FDA Regulation Legislation BioPharmaceutical

More from Rare Diseases

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window